NRSN

NEUROSENSE THERAPEUTICS LTD

NRSN·M74240108·US·Common Stock·Healthcare - Biotechnology

NRSN (NEUROSENSE THERAPEUTICS LTD) is held by 9 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($78,218), COMMONWEALTH EQUITY SERVICES, LLC ($16,400), PNC FINANCIAL SERVICES GROUP, INC. ($15,228). Net institutional sentiment: Mixed.

9
Holders
(4 Elite)
$150,412
Total Value
50% (6)
Consensus
3 buying - 3 selling
13F: Insider & Congress: Updated regularly
NRSN

Smart Money Verdict

View all
Loading verdict
Held by 9 funds
4 elite

Who's Trading

Source dates: Price Aug 17, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for NRSN.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
108,636(+121.3%)$78,2180.0%-46.54%
23
Unchanged
22,775$16,4000.0%-67.35%
0
Unchanged
21,150$15,2280.0%-49.18%
0
Unchanged
16,528$11,9000.0%-39.15%
0
Unchanged
15,870$11,4260.0%-52.04%
0
New
11,473$8,2610.0%-40.00%
23
Decreased
11,410(-4.2%)$8,2150.0%-39.15%
0
Unchanged
1,000$7570.0%-77.26%
0
New
10,515$70.0%-40.00%
17
Exited
0(-100.0%)$33,5560.0%-22.66%
0
Exited
0(-100.0%)$21,6460.0%-15.29%
0
NRSNNRSNNEUROSENSE THERAPEUTICS LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used